Cytodyn Inc. (CYDY) SEC Filings — 2025
11 SEC filings for Cytodyn Inc. (CYDY) in 2025.
Filings
- CytoDyn Inc. Files 8-K Current Report — 8-K · Dec 1, 2025
- CytoDyn Inc. Files 8-K with Corporate Updates — 8-K · Nov 21, 2025
- CytoDyn Inc. Files Additional Proxy Materials — DEFA14A · Nov 3, 2025
- CytoDyn's Net Loss Widens to $5.54M Amid R&D Spend, Cash Drains — 10-Q · Oct 10, 2025
- CytoDyn Inc. Files Proxy Materials — DEFA14A · Sep 30, 2025
- CytoDyn Seeks 28.57% Stock Authorization Hike Ahead of Annual Meeting — DEF 14A · Sep 29, 2025
- CytoDyn Remains Revenue-Less, Focuses on Leronlimab Development — 10-K · Jul 25, 2025
- CytoDyn Inc. Reports Change in Certifying Accountant — 8-K · May 16, 2025
- CytoDyn Inc. Files 8-K on Officer/Director Changes — 8-K · May 6, 2025
- CytoDyn Inc. Files 10-Q for Period Ending Feb 28, 2025 — 10-Q · Apr 14, 2025
- CytoDyn Inc. Files 10-Q for Nov 30, 2024 — 10-Q · Jan 14, 2025